CELZ

Creative Medical Technology Holdings, Inc.

$0.60

-2.42%
SectorHealthcareIndustryBiotechnologyCountryUnited States

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness.

Source: Yahoo Finance
AI summary

Price & performance

1M-26.1%
3M-10.7%
YTD-62.3%
1Y-80.0%
52-week range—
Beta1.08
Full chart and returns against a benchmark

Q-Score

33/ 100

Quality against peers; 50 is the peer median.

Growth25
Risk40
Performance37
Valuation40
Profitability36
Leverage52
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$6K-45.5%
Net income-$6M
Net margin—
Historical fundamentals

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

CELZIndustryP/E—89.69P/S—11.88EV/EBITDA—67.10P/B0.666.22PEG—4.02
Dividend yield0.00%
Every valuation metric